-
公开(公告)号:US07879991B2
公开(公告)日:2011-02-01
申请号:US10513490
申请日:2003-05-06
申请人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
发明人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
IPC分类号: C07H21/04
CPC分类号: C12N15/115
摘要: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
摘要翻译: 本发明涉及用于CGRP和胰岛淀粉样多肽的拮抗剂,其中所述拮抗剂是核酸,并且所述核酸与CGRP或胰岛淀粉样多肽结合。 所述核酸优选包含L-核苷酸。
-
公开(公告)号:US20060183700A1
公开(公告)日:2006-08-17
申请号:US10513490
申请日:2003-05-06
申请人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
发明人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
CPC分类号: C12N15/115
摘要: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
摘要翻译: 本发明涉及CGRP和胰岛淀粉样多肽的拮抗剂,其中拮抗剂是核酸,所述核酸与CGRP或胰岛淀粉样多肽结合。 所述核酸优选包含L-核苷酸。
-
公开(公告)号:US08101734B2
公开(公告)日:2012-01-24
申请号:US11400459
申请日:2006-04-07
IPC分类号: C07H21/04
CPC分类号: C12N15/115 , C12N2310/16 , C12N2310/3183 , C12N2310/351 , C12N2310/53
摘要: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3′-terminal stretch of nucleotides of the first stretch Box A hybridizes with the second stretch Box B, whereby upon hybridization a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
摘要翻译: 本发明涉及核酸,优选结合生长素释放肽,其中核酸包含第一拉伸盒A和第二拉伸盒B,其中第一拉伸盒A包含约25个连续核苷酸,第二拉伸盒B 包含约六至八个连续核苷酸,其中第一拉伸盒A的核苷酸的3'末端部分与第二拉伸盒B杂交,由此在杂交时形成第一双链结构,由此形成第一双链结构 包括凸起。
-
公开(公告)号:US20120115937A1
公开(公告)日:2012-05-10
申请号:US13356816
申请日:2012-01-24
IPC分类号: A61K31/7088 , C07K14/575 , C12Q1/68 , C07H21/04
CPC分类号: C12N15/115 , C12N2310/16 , C12N2310/3183 , C12N2310/351 , C12N2310/53
摘要: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3′-terminal stretch of nucleotides of the first stretch Box A hybridises with the second stretch Box B, whereby upon hybridisation a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
摘要翻译: 本发明涉及核酸,优选结合生长素释放肽,其中核酸包含第一拉伸盒A和第二拉伸盒B,其中第一拉伸盒A包含约25个连续核苷酸,第二拉伸盒B 包含约六至八个连续核苷酸,其中第一拉伸盒A的核苷酸的3'末端拉伸与第二拉伸盒B杂交,由此在杂交时形成第一双链结构,由此形成第一双链结构 包括凸起。
-
公开(公告)号:US20060258607A1
公开(公告)日:2006-11-16
申请号:US11400459
申请日:2006-04-07
CPC分类号: C12N15/115 , C12N2310/16 , C12N2310/3183 , C12N2310/351 , C12N2310/53
摘要: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3′-terminal stretch of nucleotides of the first stretch Box A hybridises with the second stretch Box B, whereby upon hybridisation a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
摘要翻译: 本发明涉及核酸,优选结合生长素释放肽,其中核酸包含第一拉伸盒A和第二拉伸盒B,其中第一拉伸盒A包含约25个连续核苷酸,第二拉伸盒B 包含约六至八个连续核苷酸,其中第一拉伸盒A的核苷酸的3'末端拉伸与第二拉伸盒B杂交,由此在杂交时形成第一双链结构,由此形成第一双链结构 包括凸起。
-
公开(公告)号:US09976145B2
公开(公告)日:2018-05-22
申请号:US13978804
申请日:2012-01-10
申请人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
发明人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
IPC分类号: C12N15/115 , C12N15/11 , G01N33/53 , C12N15/10
CPC分类号: C12N15/115 , C12N15/102 , C12N15/111 , C12N2310/16 , C12N2310/32 , C12N2320/13 , C12N2330/31 , G01N33/5308 , G01N2400/10 , G01N2500/04
摘要: The present invention is related to a method for generating a nucleic acid molecule capable of binding to a target molecule comprising the following steps: a) providing a reference nucleic acid molecule, wherein the reference nucleic acid molecule is capable of binding to the target molecule and wherein the reference nucleic acid molecule comprises a sequence of nucleotides, wherein the sequence of nucleotides comprises n nucleotides; b) preparing a first level derivative of the reference nucleic acid molecule, wherein the first level derivative of the reference nucleic acid molecule differs from the reference nucleic acid molecule at one nucleotide position, wherein the first level derivative is prepared by replacing the ribonucleotide at the one nucleotide position by a 2′-deoxyribonucleotide in case the reference nucleic acid has a ribonucleotide at the nucleotide position and wherein the first level derivative is prepared by replacing the 2′-deoxyribonucleotide at the one nucleotide position by a ribonucleotide in case the reference nucleic acid has a 2′-deoxyribonucleotide at the nucleotide position and wherein the nucleotide position at which the replacement is made is the modified nucleotide position; and c) repeating step b) for each nucleotide position of the reference nucleic acid molecule, thus preparing a group of first level derivatives of the reference nucleic acid molecule, wherein the group of first level derivatives of the reference nucleic acid molecule consists of n first level derivatives, wherein each of the first level derivatives of the reference nucleic acid molecule differs from the reference nucleic acid molecule by a single nucleotide replacement and wherein each of the first level derivatives of the reference nucleic acid molecule has a single modified nucleotide position which is different from the single modified nucleotide of all of the single modified nucleotide positions of the other first level derivatives of the group of first level derivatives of the reference nucleic acid molecule.
-
公开(公告)号:US20140350088A1
公开(公告)日:2014-11-27
申请号:US13978804
申请日:2012-01-10
申请人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
发明人: Florian Jarosch , Sven Klussmann , Simone Sell , Werner Purschke , Christian Maasch , Axel Vater , Kai Hohlig
IPC分类号: C12N15/115 , G01N33/53 , C12N15/10
CPC分类号: C12N15/115 , C12N15/102 , C12N15/111 , C12N2310/16 , C12N2310/32 , C12N2320/13 , C12N2330/31 , G01N33/5308 , G01N2400/10 , G01N2500/04
摘要: The present invention is related to a method for generating a nucleic acid molecule capable of binding to a target molecule comprising the following steps: a) providing a reference nucleic acid molecule, wherein the reference nucleic acid molecule is capable of binding to the target molecule and wherein the reference nucleic acid molecule comprises a sequence of nucleotides, wherein the sequence of nucleotides comprises n nucleotides; b) preparing a first level derivative of the reference nucleic acid molecule, wherein the first level derivative of the reference nucleic acid molecule differs from the reference nucleic acid molecule at one nucleotide position, wherein the first level derivative is prepared by replacing the ribonucleotide at the one nucleotide position by a 2′-deoxyribonucleotide in case the reference nucleic acid has a ribonucleotide at the nucleotide position and wherein the first level derivative is prepared by replacing the 2′-deoxyribonucleotide at the one nucleotide position by a ribonucleotide in case the reference nucleic acid has a 2′-deoxyribonucleotide at the nucleotide position and wherein the nucleotide position at which the replacement is made is the modified nucleotide position; and c) repeating step b) for each nucleotide position of the reference nucleic acid molecule, thus preparing a group of first level derivatives of the reference nucleic acid molecule, wherein the group of first level derivatives of the reference nucleic acid molecule consists of n first level derivatives, wherein each of the first level derivatives of the reference nucleic acid molecule differs from the reference nucleic acid molecule by a single nucleotide replacement and wherein each of the first level derivatives of the reference nucleic acid molecule has a single modified nucleotide position which is different from the single modified nucleotide of all of the single modified nucleotide positions of the other first level derivatives of the group of first level derivatives of the reference nucleic acid molecule.
-
公开(公告)号:US08497250B2
公开(公告)日:2013-07-30
申请号:US11913526
申请日:2006-05-04
申请人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
发明人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
IPC分类号: C12N15/115
CPC分类号: C12N15/115 , C12N2310/16 , G01N2500/04
摘要: The present invention relates to the use of a L-nucleic acid as intracellularly active agent.
摘要翻译: 本发明涉及L-核酸作为细胞内活性剂的用途。
-
公开(公告)号:US20090192100A1
公开(公告)日:2009-07-30
申请号:US11913526
申请日:2006-05-04
申请人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
发明人: Axel Vater , Christian Maasch , Sven Klussmann , Werner Purschke , Dirk Eulberg , Florian Jarosch , Klaus Buchner
IPC分类号: A61K31/7088 , C07H21/00 , C12N5/06 , C12N9/00 , G01N33/566 , C07K14/47
CPC分类号: C12N15/115 , C12N2310/16 , G01N2500/04
摘要: The present invention relates to the use of a L-nucleic acid as intracellularly active agent.
摘要翻译: 本发明涉及L-核酸作为细胞内活性剂的用途。
-
公开(公告)号:US07750140B2
公开(公告)日:2010-07-06
申请号:US10522582
申请日:2003-08-01
CPC分类号: C12N15/115 , C12N2310/16
摘要: The present invention is related to an antagonist of ghrelin, wherein the antagonist is a nucleic acid, and whereby preferably the nucleic acid is binding to ghrelin.
摘要翻译: 本发明涉及生长素释放肽的拮抗剂,其中所述拮抗剂是核酸,并且其中优选地所述核酸与生长素释放肽结合。
-
-
-
-
-
-
-
-
-